SomaticPOLEmutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis-Reference-Cited by-同舟云学术

SomaticPOLEmutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis

Published:2015-03-03 Issue:10 Volume:17 Page:1356-1364
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro Oncol

Author:

Erson-Omay E. Zeynep,Çağlayan Ahmet Okay,Schultz Nikolaus,Weinhold Nils,Omay S. Bülent,Özduman Koray,Köksal Yavuz,Li Jie,Serin Harmancı Akdes,Clark Victoria,Carrión-Grant Geneive,Baranoski Jacob,Çağlar Caner,Barak Tanyeri,Coşkun Süleyman,Baran Burçin,Köse Doğan,Sun Jia,Bakırcıoğlu Mehmet,Moliterno Günel Jennifer,Pamir M. Necmettin,Mishra-Gorur Ketu,Bilguvar Kaya,Yasuno Katsuhito,Vortmeyer Alexander,Huttner Anita J.,Sander Chris,Günel Murat

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/17/10/1356/16665424/nov027.pdf

Reference45 articles.

1. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010

2. Malignant Gliomas in Adults

3. The Definition of Primary and Secondary Glioblastoma

4. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study

5. Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the role of RNA methylation in glioma: Mechanisms, prognostic biomarkers, and therapeutic targets;Cellular Signalling;2024-12

2. TP53 mutations and survival in patients with histologically defined Glioblastoma, IDH-wildtype;Pathology - Research and Practice;2024-10

3. Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges;Cancer Letters;2024-09

4. The game-changing impact of POLE mutations in oncology—a review from a gynecologic oncology perspective;Frontiers in Oncology;2024-08-22

5. Somatic POLE Mutation and Ultra-Hypermutated Genotype in a De Novo High-Grade, Isocitrate Dehydrogenase Wild-Type Glioma: Treatment Implications;JCO Precision Oncology;2024-02